Correction: Measuring Atrioventricular Valve Regurgitation Using 4D Flow Cardiovascular Magnetic Resonance Post-Fontan - Scorecard - MDSpire

Correction: Measuring Atrioventricular Valve Regurgitation Using 4D Flow Cardiovascular Magnetic Resonance Post-Fontan

  • By

  • Husayn M. Ladha

  • Justin C. Wang

  • Yu Li

  • Adam B. Christopher

  • Jacqueline Kreutzer

  • Rajesh Krishnamurthy

  • Francesca Raimondi

  • Joshua D. Robinson

  • Yue-Hin Loke

  • Laura J. Olivieri

  • Mark A. Fogel

  • Rafael Ceschin

  • Rahul H. Rathod

  • Tarek Alsaied

  • July 15, 2026

Share

Clinical Scorecard: Correction: Assessment of Atrioventricular Valve Regurgitation via 4D Flow Cardiovascular Magnetic Resonance Following Fontan Procedure

At a Glance

CategoryDetail
ConditionAtrioventricular Valve Regurgitation
Key MechanismsAssessment via 4D Flow Cardiovascular Magnetic Resonance
Target PopulationPatients post-Fontan procedure
Care SettingPediatric Cardiology

Key Highlights

  • Correction of decimal values in Table 4
  • Updated collaborators list
  • Focus on AVVR assessment following Fontan procedure

Guideline-Based Recommendations

Diagnosis

  • Include relevant guidelines for diagnosis.

Management

  • Include relevant guidelines for management.

Monitoring & Follow-up

  • Include relevant guidelines for monitoring.

Risks

  • Include relevant guidelines for risks.

Patient & Prescribing Data

Provide specific treatment insights related to the patient population.

Clinical Best Practices

  • best_practices

Related Resources & Content

Original Source(s)

Correction: Measuring Atrioventricular Valve Regurgitation Using 4D Flow Cardiovascular Magnetic Resonance Post-Fontan

  • by Husayn M. Ladha, Justin C. Wang, Yu Li, Adam B. Christopher, Jacqueline Kreutzer, Rajesh Krishnamurthy, Francesca Raimondi, Joshua D. Robinson, Yue-Hin Loke, Laura J. Olivieri, Mark A. Fogel, Rafael Ceschin, Rahul H. Rathod, Tarek Alsaied

  • July 15, 2026

Related Content

Lipid Screening and Dyslipidemia in Children with Congenital Heart Disease

Single Ventricle Infant Deaths Without Transplant Referral: Room for Improvement?

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.